Cargando…
Clinical review: Guide to pharmacological management in pediatric obesity medicine
INTRODUCTION: Newer pharmacotherapy agents (anti-obesity medication [AOM]) are revolutionizing the management of children and adolescents with obesity. Previously, treatment based on intensive behavioral therapy involved many patient and family contact hours and yielded improvements in obesity statu...
Autores principales: | O'Hara, Valerie, Cuda, Suzanne, Kharofa, Roohi, Censani, Marisa, Conroy, Rushika, Browne, Nancy T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661861/ https://www.ncbi.nlm.nih.gov/pubmed/37990657 http://dx.doi.org/10.1016/j.obpill.2023.100066 |
Ejemplares similares
-
Metabolic, behavioral health, and disordered eating comorbidities associated with obesity in pediatric patients: An Obesity Medical Association (OMA) Clinical Practice Statement 2022
por: Cuda, Suzanne E., et al.
Publicado: (2022) -
Medication-induced weight gain and advanced therapies for the child with overweight and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement 2022
por: Cuda, Suzanne, et al.
Publicado: (2022) -
Social consequences and genetics for the child with overweight and obesity: An obesity medicine association (OMA) clinical practice statement 2022
por: Cuda, Suzanne, et al.
Publicado: (2022) -
Corrigendum to “Social consequences and genetics for the child with overweight and obesity: An obesity medicine association (OMA) clinical practice statement 2022” [Obes. Pillars 3 (2022) 100032]
por: Cuda, Suzanne, et al.
Publicado: (2022) -
Pediatric Obesity Algorithm: A Practical Approach to Obesity Diagnosis and Management
por: Cuda, Suzanne E., et al.
Publicado: (2019)